Antifungal prophylaxis in pediatric lung transplantation: An international multicenter survey

Pediatric Transplantation

Volumn 18, Issue 4, 2014, Pages 393-397

  Mead, Lee ^a   Danziger Isakov, Lara A ^b   Michaels, Marian G ^c   Goldfarb, Samuel ^d   Glanville, Allan R ^a   Benden, Christian ^e  

^a ST VINCENT S HOSPITAL   (Australia)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

antifungal prophylaxis; children; lung transplantation; pediatrics

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECHINOCANDIN; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CHILD; DRUG MONITORING; EUROPE; FUNGAL COLONIZATION; GRAFT RECIPIENT; HEALTH CENTER; HUMAN; LUNG TRANSPLANTATION; MONOTHERAPY; MULTICENTER STUDY; MYCOSIS; PEDIATRIC SURGERY; PROPHYLAXIS; REVIEW; TREATMENT DURATION; UNITED STATES; ADULT; ANTIBIOTIC PROPHYLAXIS; CLINICAL PRACTICE; HEALTH CARE SURVEY; LUNG DISEASES, FUNGAL; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; CHILD; EUROPE; HEALTH CARE SURVEYS; HUMANS; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; UNITED STATES;

EID: 84900022127     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12263     Document Type: Review

References (17)

1. Benden C,. Specific aspects of children and adolescents undergoing lung transplantation. Curr Opin Organ Transplant 2012: 17: 509-514.
2. Benden C, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official pediatric lung and heart-lung transplantation report-2012. J Heart Lung Transplant 2012: 31: 1087-1095.
3. Liu M, Worley S, Mallory GB, et al. Fungal infections in pediatric lung transplant recipients: Colonization and invasive disease. J Heart Lung Transplant 2009: 28: 1226-1230.
4. Danziger-Isakov LA, Worley S, Arrigain S, et al. Increased mortality after pulmonary fungal infections within the first year after pediatric lung transplantation. J Heart Lung Transplant 2008: 27: 655-661.
5. Schaenman JM,. Is universal antifungal prophylaxis mandatory in lung transplant patients? Curr Opin Infect Dis 2013: 26: 317-325.
6. Solé A, Moran P, Salavert M, et al. Aspergillus infections in lung transplant recipients: Risk factors and outcome. Clin Microbiol Infect 2005: 11: 359-365.
7. Weigt SS, Elashoff RM, Huang C, et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009: 9: 1903-1911.
8. Magill SS, Dropulic LK,. Antifungal prophylaxis in transplant recipients: Where do we go from here? Transpl Infect Dis 2006: 8: 187-189.
9. Singh NM, Husain S,; AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation. Am J Transplant 2013: 13: 228-241.
10. Levine SM,. Transplant/Immunology Network of the American College of Chest Physicians: A survey of clinical practice of lung transplantation in North America. Chest 2004: 125: 1224-1238.
11. Dummer JS, Lazariashvilli N, Barnes J, et al. A survey of antifungal management in lung transplantation. J Heart Lung Transplant 2004: 23: 1376-1381.
12. Husain S, Zaldonis D, Kusne S, et al. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006: 8: 213-218.
13. Neoh CF, Snell GI, Kotsimbos T, et al. Antifungal prophylaxis in lung transplantation-a world-wide survey. Am J Transplant 2011: 11: 361-366.
14. Avery R,. Antifungal prophylaxis in lung transplantation. Semin Respir Crit Care Med 2011: 32: 717-726.
15. Brett J, Chong OF, Graham GG, et al. Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients. Ther Drug Monit 2013: 35: 133-136.
16. Chen J, Chan C, Colantonio D, Seto W,. Therapeutic drug monitoring of voriconazole in children. Ther Drug Monit 2012: 34: 77-84.
17. Lomas J, Anderson GM, Dominick-Pierre K, et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989: 321: 1306-1311.